We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Updates Advice on Pharmacologic Classes for Prescribing Information
FDA Updates Advice on Pharmacologic Classes for Prescribing Information
The FDA released an updated version of its 2013 Manual of Policies and Procedures (MAPP) outlining CDER’s procedures for determining pharmacologic classes for use in prescribing information for drugs.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor